Death during study period · people with liver metastases
It is very uncertain whether transarterial embolisation and transarterial chemoembolisation changes mortality at 44 months from trial entry Number of participants compared with no intervention (very low certainty).
1 finding from 1 review
Tumour response measures · people with liver metastases
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life · people with liver metastases
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events and complications · people with liver metastases
1 finding from 1 review
Death during study period · people with liver metastases
It is very uncertain whether transarterial chemoembolisation changes mortality at 44 months from trial entry Number of participants compared with no intervention (very low certainty).
1 finding from 1 review
Survival time Median (range) survival time after trial entry Survival time Median (range) survival time from diagnosis · people with liver metastases
1 finding from 1 review
Tumour response measures · people with liver metastases
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Survival time Median (range) survival time after trial entry Survival time Median (range) survival time from diagnosis · people with liver metastases
1 finding from 1 review
Health‐related quality of life · people with liver metastases
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events and complications · people with liver metastases
1 finding from 1 review
Tumour response measures · people with liver metastases
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life · people with liver metastases
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events and complications · people with liver metastases
1 finding from 1 review
Death during study period · people with liver metastases
It is very uncertain whether transarterial embolisation changes mortality at 44 months from trial entry Number of participants compared with no intervention (very low certainty).
1 finding from 1 review
Survival time Median (range) survival time after trial entry Survival time Median (range) survival time from diagnosis · people with liver metastases
1 finding from 1 review
Overall pain scores unclear measurement instrument (6 months) · women with endometriosis
1 finding from 1 review
Adverse events: conversion to laparotomy · women with endometriosis
1 finding from 1 review
Adverse events · endometriosis
Laparoscopic ablation and uterine nerve transaction showed no clear difference in adverse events compared with diagnostic laparoscopy (low certainty).
1 finding from 1 review
Overall pain scores (reduction in VAS at 12 months) · endometriosis
1 finding from 1 review
Quality of life (9 months) – EHP‐30 pain · endometriosis
1 finding from 1 review